DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Felip Font E. et al.
Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC).
Ann Onc 2017;
28 (Suppl. 05) v460-v496
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.